ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.74
0.62%
US Tech 100
17,633.60
0.18%
S&P 500
5,211.07
0.45%
US Dollar vs CAD
1.3678
-0.36%
Bitcoin
62,297.11
1.81%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) News

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABIO
DateTimeSourceHeadlineSymbolCompany
04/25/20243:15PMGlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
04/05/202412:09PMPR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
04/03/20246:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
04/03/20246:30AMGlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
02/07/202412:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
02/06/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
02/01/20243:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
02/01/20243:35PMGlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
02/01/20243:15PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
01/31/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
01/31/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
12/19/20233:25PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
12/19/20233:20PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
12/19/20233:15PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
12/05/20233:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
12/04/20233:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
10/18/20233:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
10/18/20233:25PMGlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
10/18/20233:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
09/11/20233:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
07/21/20233:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
07/21/20233:25PMGlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
07/21/20233:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
04/24/20233:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
RDAR
Raadr (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
INQD
Indoor Harvest (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
AHRO
Authentic (CE)
USOTC
TKMO
Tekumo (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved